1. Sadovnick, AD, Remick, RA, Allen, J, Swartz, E, Yee, IM, Eisen, K, Farquhar, R, Hashimoto, SA, Hooge, J, Kastrukoff, LF
Morrison, W (1996) Depression and multiple sclerosis. Neurology 46, 628–632.
2. Minden, SL
Schiffer, RB (1990) Affective disorders in multiple sclerosis review and recommendations for clinical research. Arch Neurol 47, 98–104.
3. D’alisa, S, Miscio, G, Baudo, S, Simone, A, Tesio, L
Mauro, A (2006) Depression is the main determinant of quality of life in multiple sclerosis: a classification-regression (CART) study. Disabil Rehabil 28, 307–314.
4. Arnett, PA, Higginson, CI, Voss, WD, Wright, B, Bender, WI, Wurst, JM
Tippin, JM (1999) Depressed mood in multiple sclerosis: relationship to capacity-demanding memory and attentional functioning. Neuropsychology 13, 434.
5. Mohr, DC, Goodkin, DE, Likosky, W, Gatto, N, Baumann, KA
Rudick, RA (1997) Treatment of depression improves adherence to interferon beta-1b therapy for multiple sclerosis. Arch Neurol 54, 531–533.
6. Feinstein, A (2002) An examination of suicidal intent in patients with multiple sclerosis. Neurology 59, 674–678.
7. Marrie, RA, Horwitz, R, Cutter, G, Tyry, T, Campagnolo, D
Vollmer, T (2009) The burden of mental comorbidity in multiple sclerosis: frequent, underdiagnosed, and undertreated. Mult Scler J 15, 385–392.
8. Mitchell, AJ, Baker‐Glenn, EA, Granger, L
Symonds, P (2010) Can the Distress Thermometer be improved by additional mood domains? Part I. Initial validation of the Emotion Thermometers tool. Psychooncology 19, 125–133.
9. Mitchell, AJ, Baker‐Glenn, EA, Park, B, Granger, L
Symonds, P (2010) Can the Distress Thermometer be improved by additional mood domains? Part II. What is the optimal combination of Emotion Thermometers? Psychooncology 19, 134–140.
10. Kroenke, K, Spitzer, RL
Williams, JB (2001) The PHQ‐9: validity of a brief depression severity measure. J Gen Intern Med 16, 606–613.
11. Gunzler, DD, Perzynski, A, Morris, N, Bermel, R, Lewis, S
Miller, D (2015) Disentangling multiple sclerosis and depression: an adjusted depression screening score for patient-centered care. J Behav Med 38, 237–250.
12. Rampling, J, Mitchell, AJ, Von Oertzen, T, Docker, J, Jackson, J, Cock, H
Agrawal, N (2012) Screening for depression in epilepsy clinics. A comparison of conventional and visual‐analog methods. Epilepsia 53, 1713–1721.
13. Jacobsen, PB, Donovan, KA, Trask, PC, Fleishman, SB, Zabora, J, Baker, F
Holland, JC (2005) Screening for psychologic distress in ambulatory cancer patients. Cancer 103, 1494–1502.
14. Akizuki, N, Akechi, T, Nakanishi, T, Yoshikawa, E, Okamura, M, Nakano, T, Murakami, Y
Uchitomi, Y (2003) Development of a brief screening interview for adjustment disorders and major depression in patients with cancer. Cancer 97, 2605–2613.
15. Roth, AJ, Kornblith, AB, Batel‐Copel, L, Peabody, E, Scher, HI
Holland, JC (1998) Rapid screening for psychologic distress in men with prostate carcinoma: a pilot study. Cancer 82, 1904–1908.
16. Cuijpers, P, Dekker, J, Noteboom, A, Smits, N
Peen, J (2007) Sensitivity and specificity of the Major Depression Inventory in outpatients. BMC Psychiatry 7, 39.
17. Bech, P, Rasmussen, NA, Olsen, LR, Noerholm, V
Abildgaard, W (2001) The sensitivity and specificity of the Major Depression Inventory, using the Present State Examination as the index of diagnostic validity. J Affect Disord 66, 159–164.
18. Zigmond, AS
Snaith, RP (1983) The hospital anxiety and depression scale. Acta Psychiatr Scand 67, 361–370.
19. Honarmand, K
Feinstein, A (2009) Validation of the Hospital Anxiety and Depression Scale for use with multiple sclerosis patients. Mult Scler J 15, 1518–1524.
20. Buderer, NM (1996) Statistical methodology: I. Incorporating the prevalence of disease into the sample size calculation for sensitivity and specificity. Acad Emerg Med 3, 895–900.
21. Patten, SB, Fridhandler, S, Beck, CA
Metz, LM (2003) Depressive symptoms in a treated multiple sclerosis cohort. Mult Scler J 9, 616–620.
22. Patten, SB, Beck, CA, Williams, JV, Barbui, C
Metz, LM (2003) Major depression in multiple sclerosis: a population-based perspective. Neurology 61, 1524–1527.
23. Chwastiak, L, Ehde, DM, Gibbons, LE, Sullivan, M, Bowen, JD
Kraft, GH (2002) Depressive symptoms and severity of illness in multiple sclerosis: epidemiologic study of a large community sample. Am J Psychiatry 159, 1862–1868.
24. Gilbody, S, Sheldon, T
Wessely, S (2006) Should we screen for depression? BMJ 332, 1027–1030.
25. Boeschoten, RE, Braamse, AM, Beekman, AT, Cuijpers, P, van Oppen, P, Dekker, J
Uitdehaag, BM (2017) Prevalence of depression and anxiety in multiple sclerosis: a systematic review and meta-analysis. J Neurol Sci 372, 331–341.
26. Knippenberg, S, Bol, Y, Damoiseaux, J, Hupperts, R
Smolders, J (2011) Vitamin D status in patients with MS is negatively correlated with depression, but not with fatigue. Acta Neurol Scand 124, 171–175.
27. Parker, GB, Brotchie, H
Graham, RK (2017) Vitamin D and depression. Journal Affect Disord 208, 56–61.
28. Rolf, L, Muris, AH, Bol, Y, Damoiseaux, J, Smolders, J
Hupperts, R (2017) Vitamin D3 supplementation in multiple sclerosis: symptoms and biomarkers of depression. J Neurol Sci 378, 30–35.
29. Knippenberg, S, Damoiseaux, J, Bol, Y, Hupperts, R, Taylor, BV, Ponsonby, AL, Dwyer, T, Simpson, S
van der Mei, IA (2014) Higher levels of reported sun exposure, and not vitamin D status, are associated with less depressive symptoms and fatigue in multiple sclerosis. Acta Neurol Scand 129, 123–131.
30. Silva, MC
Furlanetto, TW (2015) Does serum 25-hydroxyvitamin D decrease during acute-phase response? A systematic review. Nutrition Res 35, 91–96.
31. American Psychiatric Association (2013) Highlights of changes from DSM-IV-TR to DSM-5. Washington DC.
32. World Health Organisation (2013) ICD-11. Available at https://icd.who.int/ Accessed November 20, 2018.
33. Horwitz, AV
Wakefield, JC (2007) The loss of sadness: How psychiatry transformed normal sorrow into depressive disorder. New York: Oxford University Press.
34. Mitchell, AJ, Ioannou, N, Rampling, JM, Sajid, A, von Oertzen, TJ, Cock, HR
Agrawal, N (2013) Which symptoms are indicative of depression in epilepsy settings? An analysis of the diagnostic significance of somatic and non-somatic symptoms. J Affect Disord 150, 861–867.
35. Kurtzke, JF (1983) Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology. 33, p1444.